Lombard Odier Asset Management Europe Ltd cut its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 54.5% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 26,109 shares of the conglomerate’s stock after selling 31,312 shares during the quarter. Lombard Odier Asset Management Europe Ltd’s holdings in Danaher were worth $4,950,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in DHR. Northwestern Mutual Wealth Management Co. lifted its stake in Danaher by 303.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after purchasing an additional 186,584 shares during the last quarter. SeaBridge Investment Advisors LLC bought a new stake in Danaher in the 4th quarter valued at $4,477,000. Legal & General Group Plc increased its position in Danaher by 1.0% during the fourth quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock worth $1,029,061,000 after acquiring an additional 43,169 shares during the period. Robeco Institutional Asset Management B.V. increased its holdings in shares of Danaher by 220.2% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 674,373 shares of the conglomerate’s stock worth $154,377,000 after purchasing an additional 463,764 shares during the period. Finally, Whittier Trust Co. raised its holdings in Danaher by 12.2% in the 4th quarter. Whittier Trust Co. now owns 292,894 shares of the conglomerate’s stock valued at $69,296,000 after acquiring an additional 31,790 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Danaher Price Performance
Shares of DHR opened at $195.25 on Monday. The firm has a market cap of $137.26 billion, a PE ratio of 34.68, a P/E/G ratio of 2.43 and a beta of 0.78. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The firm has a fifty day simple moving average of $188.36 and a two-hundred day simple moving average of $195.35.
Danaher Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, July 31st. Shareholders of record on Friday, June 26th were paid a $0.40 dividend. The ex-dividend date of this dividend was Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.8%. Danaher’s dividend payout ratio (DPR) is presently 28.42%.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on DHR shares. Citigroup started coverage on Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective for the company. HSBC dropped their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Argus decreased their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Friday, April 24th. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a report on Friday, April 17th. Finally, Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $228.91.
View Our Latest Stock Analysis on Danaher
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
- AbbVie Quietly Solved Its Biggest Problem—Now What?
- Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
- Strategy’s Structural Strength: Hidden in a $8 Billion Illusion
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
